SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-113907
Filing Date
2024-04-25
Accepted
2024-04-25 16:12:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d823314ddefa14a.htm DEFA14A 10782
2 GRAPHIC g823314g06b06.jpg GRAPHIC 210877
3 GRAPHIC g823314g07g07.jpg GRAPHIC 179802
  Complete submission text file 0001193125-24-113907.txt   550297
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38096 | Film No.: 24876441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)